Immunocore Holdings plc - ADR
News
Immunocore to present at the 2024 Cantor Global Healthcare Conference
Globe Newswire Immunocore to present at the 2024 Cantor Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 12 September 2024) Immunocore Holdings plc (Nasdaq: IMCR...\n more…
Candriam S.C.A. Increases Position in Immunocore Holdings plc (NASDAQ:IMCR)
Ticker Report Candriam S.C.A. boosted its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 65.8% in the 2nd quarter, according to the company in its most recent 13F filing with the...\n more…
Immunocore Holdings (IMCR) Receives a Buy from Barclays
TipRanks Financial Blog Barclays analyst Peter Lawson assigned a Buy rating to Immunocore Holdings (IMCR - Research Report) today and set a price target of $66.00. The com...\n more…
Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Principal Financial Group Inc.
Zolmax Principal Financial Group Inc. trimmed its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 15.5% in the second quarter, according to its most recent disclosure with the Securities...\n more…
Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics
PR Newswire Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics PR Newswire BASEL, Switzerland, Sept. 5, 2024...\n more…
Immunocore Holdings plc (NASDAQ:IMCR) Given Average Rating of "Moderate Buy" by Brokerages
Ticker Report Shares of Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, Marketbeat...\n more…